American Health Systems Corporation Appoints Alan L. Bess, MD as President and CEO

American Health Systems Corporation is a internationally recognized Drug Safety and Pharmacovigilance service provider.

New York, NY, April 23, 2009 --(PR.com)-- American Health Systems Corporation, an internationally recognized Drug Safety and Pharmacovigilance service provider, has named Alan L. Bess, MD as President and Chief Executive Officer. He replaces co-founder Stephen Richardson PhD who will continue to serve as Chief Financial Officer and a strategic advisor.

"Dr Bess has brought a new strategic direction and operational excellence to American HSC in his role as Chief Medical Officer over the past several months and he is the ideal executive to lead the company” said Dr Richardson. “He has been responsible for the delivery of pharmacovigilance support to several of the world's top pharmaceutical companies, implementing high quality standards, excellent customer service, and outstanding compliance”.

Dr Bess is a senior pharmaceutical executive with 28 years of demonstrated success in Drug Safety and Pharmacovigilance. He is an FDA-recognized expert on Drug Safety and a high-energy leader with a strong commitment to quality. He has a proven track record of building high performance Drug Safety organizations. He has written numerous safety-related articles, abstracts, letters, and editorials for medical and industry journals.

Prior to joining American Health Systems Corporation, Dr Bess was Vice President and Head of Clinical Drug Safety & Epidemiology at Novartis (2000-2008), Vice President and Head of Drug Safety at Hoffmann-La Roche (1994-2000), Drug Safety Section Head, Hoffmann-La Roche (1988-1994), and Head of Drug Safety & Medical Affairs at Abbott Laboratories (1982-1988).

Dr Bess obtained his medical degree from Temple University School of Medicine. He did his postgraduate medical training at Thomas Jefferson University Hospital and the Albert Einstein Medical Centers in Philadelphia, PA. He is on staff at The Ernest Mario School of Pharmacy at Rutgers University and The Albert Einstein Medical Center.

"The global drug safety and regulatory environments have changed significantly and are now much more demanding," said Dr Bess. "The regulations require experienced interpretation and sponsors face increased accountability for patient safety. American HSC has the broad experience and the infrastructure to help companies meet stricter regulatory requirements with cost-effective solutions. I am very proud to serve as President and CEO of this innovative company. My priority is to stay focused on the many opportunities that lie before us. I sincerely appreciate the leadership, friendship, and support of Dr Stephen Richardson over the past several months”.

About American Health Systems Corporation
American HSC is an internationally recognized leader in Drug Safety consulting, offering a full range of integrated services to help develop, implement, and maintain Drug Safety, Pharmacovigilance, and Pharmacoepidemiology programs. Its mission is to offer strategically sound, expertly staffed, and flawlessly executed Drug Safety solutions with an impressive complement of both strategic and tactical support. American HSC delivers a unique combination of highly skilled and experienced drug safety experts, exclusive technology, and best practices in drug safety and pharmacovigilance. To learn more about American HSC please visit their website at www.americanhsc.net, or send an e-mail to info@americanhsc.net

###
Contact
American Health Systems Corporation
Kimberly Sautter
973 907 7629
www.americanhsc.net
ContactContact
Categories